UPDATE 5-Lilly makes $8 bln bet on drugs for rare cancers with Loxo Oncology buy
January 07, 2019 at 17:48 PM EST
Eli Lilly said on Monday it will buy Loxo Oncology Inc for $8 billion, an expensive bet on a pipeline of cancer drugs that target rare genetic mutations and the biggest acquisition in the drugmaker's 143-year history.